Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02051452 · ClinicalTrials.gov registry record · Phase 1
Reversal of General Anesthesia With Methylphenidate
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT02051452: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT02051452 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02051452, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The aim of this study is to investigate whether methylphenidate (Ritalin) can actively induce emergence from general anesthesia in patients having a pancreaticoduodenectomy (Whipple procedure), a pancreatectomy, or a prostatectomy.
Interventions
- OTHER Saline
- DRUG Methylphenidate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2014-11 |
| Est. Completion | 2018-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02051452
The ClinicalTrials.gov registry entry for NCT02051452 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02051452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02051452 about?
NCT02051452 is a clinical study titled "Reversal of General Anesthesia With Methylphenidate". The aim of this study is to investigate whether methylphenidate (Ritalin) can actively induce emergence from general anesthesia in patients having a pancreaticoduodenectomy (Whipple procedure), a pancreatectomy, or a prostatectomy.
What is the current status of trial NCT02051452?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2014-11. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02051452?
The interventions under investigation include: Saline (OTHER), Methylphenidate (DRUG).
Who is sponsoring clinical trial NCT02051452?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.